Peripheral Immune Profile Alterations in Treatment‐Naïve Immune‐Mediated Necrotizing Myopathy
Muscle & Nerve · 2026-06 · 73 (6) · 1103-1108
DOI: 10.1002/mus.70238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 03.04.2026. Verfasst von Kaikai Huo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Muscular Diseases. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.
Abstract (Originalsprache)
Introduction/Aims Immune‐mediated necrotizing myopathy (IMNM) is a severe autoimmune myopathy causing proximal muscle weakness. Its underlying immunopathogenesis remains incompletely understood, limiting the development of targeted therapies. To elucidate disease mechanisms and inform therapeutic strategies, this study characterized the peripheral immune profile of treatment‐naïve IMNM patients.
Methods
This retrospective study analyzed serum cytokine levels, complement proteins (C3, C4), immunoglobulins (IgA, IgG, and IgM), and peripheral blood lymphocyte subsets in 28 treatment‐naïve IMNM patients during the active disease phase and 25 healthy controls at Tongji Hospital from August 2023 to March 2025.
Results
Compared with healthy controls, IMNM patients showed significantly elevated serum concentrations of interleukin‐6 and interferon‐γ (both p < 0.001). IgG and IgM levels were also markedly higher in the IMNM group ( p = 0.003; p = 0.002). The number and percentage of B cells were significantly increased in IMNM patients (both p = 0.004). The number and percentage of CD8 + T cells were similarly elevated ( p = 0.009; p = 0.004). In contrast, the proportion of CD4 + T cells was significantly reduced ( p = 0.002), and the absolute count of natural killer cells was also significantly reduced ( p = 0.004).
Discussion
IMNM exhibits a distinct peripheral immune landscape, characterized by enhanced humoral immunity potentially driven by CD8 + T cell‐mediated mechanisms, accompanied by reduced circulating natural killer cells. These findings suggest potential biomarkers for disease activity and may inform targeted immunotherapies. Further studies are needed to validate these immune alterations and clarify their role in IMNM pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
ORCID-Profile: Xue Ma
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
Zitieren
APA
Huo, K., Ge, H., Gao, H., & Ma, X. (2026). Peripheral Immune Profile Alterations in Treatment‐Naïve Immune‐Mediated Necrotizing Myopathy. Muscle & Nerve, 73(6), 1103-1108. https://doi.org/10.1002/mus.70238
Vancouver
Huo K, Ge H, Gao H, Ma X. Peripheral Immune Profile Alterations in Treatment‐Naïve Immune‐Mediated Necrotizing Myopathy. Muscle & Nerve. 2026;73(6):1103-1108. doi:10.1002/mus.70238
BibTeX
@article{Huo2026,
author = {Huo, Kaikai and Ge, Huizhen and Gao, Huajie and Ma, Xue},
title = {Peripheral Immune Profile Alterations in Treatment‐Naïve Immune‐Mediated Necrotizing Myopathy},
journal = {Muscle & Nerve},
year = {2026},
volume = {73},
number = {6},
pages = {1103--1108},
doi = {10.1002/mus.70238}
}
EUVIMED